About Gfree Bio

  • Gfree Bio has played a major role in advancing numerous patented new molecular entities

  • Provided expert testimony for a successful patent litigation case in excess of $1 billion

  • Contributed to new clinical candidates

Resmetirom

Meet Our Team

CV

Chuck Reynolds, PhD

Founder

  • Led modeling teams at J&J and Ansaris that pursued drug discovery programs for a wide variety of targets
  • Published extensively in the field of computational chemistry
  • Gfree Bio has grown to support successful drug discovery programs for more than 60 companies

Kate Holloway, PhD

Principal Scientist

  • Research scientist at Merck for more than 30 years
  • Key contributor to 4 marketed drugs
  • Widely published in the field of computational chemistry